Oncology Is Booming But Cost Outlook Is Grim, IMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The cost of oncology therapeutics and supportive care drugs grew 11.5% to $107bn in 2015 at constant exchange rates and is expected to reach $150bn globally in 2020, according to a new IMS report.